Investing First patient dosed in Phase IIb imaging for Brain Mets by admin April 28, 2025 April 28, 2025 Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets Download the PDF here. This post appeared first on investingnews.com previous post Binding Commitments Received for A$1.0 Million under Convertible Note Placement next post RHI: Acqn of royalty over Sandstone Gold Project tenements You may also like CEO Appointment May 19, 2025 Triumph Gold: Multi-million-ounce, District-scale Gold Assets in the... May 7, 2025 John Feneck: Gold Backdrop Looks “Amazing,” Plus 7... April 22, 2025 High Grade Results Continue in Sandstone Drilling May 8, 2025 Is Now a Good Time to Buy Bitcoin? May 14, 2025 Crypto Market Recap: Coinbase to Join S&P 500,... May 16, 2025 xU3O8 (uranium.io): Pioneering Physical Uranium Ownership Powered by... May 2, 2025 Top 5 Canadian Mining Stocks This Week: Group... May 11, 2025 Multiple New Multi-Commodity Targets May 12, 2025 Cartier Resources Closes Offering with Paradigm Capital and... April 24, 2025
